Register Now for the REdI 2021 Conference, July 19-23
Save the date: July 19-23. Registration is free.
If your email program has trouble displaying this email, view as a webpage.
The Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH), Center for Drug Evaluation and Research (CDER), and Center for Biologics Evaluation and Research (CBER) are pleased to invite you to the 2021 Regulatory Education for Industry (REdI) Annual Conference.
Janet Woodcock, M.D., Acting Commissioner of the US Food and Drug Administration
PLENARY The plenary session will reflect on the FDA's use of Emergency Use Authorizations (EUAs) and other resources in making drug, device, and biological products available to support the public health response to the COVID-19 pandemic.
The program topics feature the following:
Drug Track (July 19-20)
CDER NextGen Portal
Communication Best Practices
Drug Development and Precision Medicine
Device Track (July 21-22)
Premarket submissions
Quality system principles
Additive manufacturing
Biologic Track (July 22-23)
"Tissue Rule": Regulation of products under 21 CFR part 1271
Development and regulation of cellular therapies, gene therapies, and plasma-derived therapeutics
Expedited development programs for advanced therapies
Attend virtually. Participants can join us virtually by Adobe Connect. To test your PC, visit: Adobe Connect Diagnostic Test.
Continuing Education. This conference has been pre-approved by RAPS, SOCRA, SQA, and ACRP. Credit hour guidelines vary by organization.
For technical assistance with the webcast, please email at info@sbiaevents.com.
This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 10903 New Hampshire Ave · Silver Spring, MD · 20993-0002 · 1-888-INFO-FDA
No comments:
Post a Comment